Novartis loss-making vaccines division gets British boost

March 21, 2014 11:11 AM

6 0

Novartis loss-making vaccines division gets British boost

ZURICH (Reuters) - The turnaround prospects for Novartis' loss-making vaccines division were given a boost on Friday as a key committee recommended including the Swiss drugmaker's meningitis B vaccine on Britain's routine vaccination programme.

The Basel-based drugmaker said the UK Joint Committee on Vaccination and Immunisation (JCVI) had recommended that infants from two months of age be vaccinated with Bexsero to help protect against "MenB", a bacterial infection that can kill in 24 hours and poses the greatest risk to infants.

Read more

To category page

Loading...